Data Science and Advanced Analytics Internship (hybrid) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sobi - Swedish Orphan Biovitrum AB (publ) · 17 hours ago

Data Science and Advanced Analytics Internship (hybrid)

Sobi is a global biopharmaceutical company dedicated to rare diseases, and they are seeking interns for their Data Science and Advanced Analytics program. The internship offers a unique perspective into the pharmaceutical industry, allowing interns to contribute to analytics and AI initiatives that support sales and marketing business needs.

BiotechnologyGeneticsMedicalPharmaceutical
badNo H1Bnote

Responsibilities

Use deep analytics and AI type initiatives to support sales and marketing business needs
Deadline-driven with a high level of organizational and planning skills
Strong analytical, problem-solving, and oral and written communication skills
Ability to work well in teams, effectively manage projects, and present ideas clearly and concisely
Global mindset to grow in a diverse work environment
Excellent communication and leadership skills
Other specific responsibilities will be dependent upon the needs of the mentor and qualifications/skillset of the candidate

Qualification

Advanced AnalyticsMathematicsAnalytical skillsProblem-solvingCommunication skillsTeamworkProject managementLeadership

Required

Candidates must be currently enrolled at an accredited university in the Boston metro area
Must be authorized to work in the US without sponsorship (i.e., Sobi, Inc. will not sponsor interns)
Minimum GPA 3.0
Must be undergraduate students with at least 2 years of university studies before internship
Return to university for at least one semester post-internship

Preferred

Preferred Majors include Advanced Analytics or Mathematics

Benefits

Competitive compensation for your work
Generous time off policy
Opportunity to broaden your horizons by attending popular conferences
Emphasis on work/life balance
Collaborative and team-oriented environment
Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

Company

Sobi - Swedish Orphan Biovitrum AB (publ)

twittertwitter
company-logo
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.

Funding

Current Stage
Public Company
Total Funding
$825.99M
2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO

Leadership Team

leader-logo
Guido Oelkers
Chief Executive Officer
Company data provided by crunchbase